Product Description
Xtandi (Enzalutamide) 40mg x 112 Soft Capsules is a prescription medication used for the treatment of prostate cancer. It works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and spread of cancer cells in men with metastatic castration-resistant prostate cancer (mCRPC).

Indications
Xtandi is indicated for the treatment of:

Metastatic castration-resistant prostate cancer (mCRPC)
Non-metastatic castration-resistant prostate cancer (nmCRPC)


Dosage and Administration
The recommended dosage of Xtandi is 160 mg (four 40 mg soft capsules) taken orally once daily. It can be taken with or without food. It is important to swallow the capsules whole and not to chew or open them.

Side Effects
Common side effects of Xtandi may include:

Fatigue
Hot flashes
Hypertension
Diarrhea
Nausea

Patients should report any severe side effects to their healthcare provider immediately.

Precautions
Before starting treatment with Xtandi, patients should inform their healthcare provider of any pre-existing conditions, especially:

Seizure disorders
History of heart problems
Liver function impairment


Drug Interactions
Xtandi may interact with other medications. Patients should provide their healthcare provider with a complete list of all medications, supplements, and herbal products they are currently taking.

Storage
Store Xtandi at room temperature, away from moisture and heat. Keep out of reach of children.

Conclusion
Xtandi (Enzalutamide) offers a targeted approach to managing prostate cancer, providing patients with an effective treatment option. Always consult with a healthcare professional before starting any new medication.